The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of hPG80 (circulating progastrin) in IDH-wild type glioblastoma treated with radio-chemotherapy.
 
Ludovic Doucet
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Takeda
Travel, Accommodations, Expenses - Takeda
 
Axel Cailleteau
No Relationships to Disclose
 
Loig Vaugier
No Relationships to Disclose
 
Carole Gourmelon
Consulting or Advisory Role - Eisai; Novocure
Travel, Accommodations, Expenses - Novartis
 
Mathilde Bureau
No Relationships to Disclose
 
Celine Salaud
No Relationships to Disclose
 
Vincent Roualdes
No Relationships to Disclose
 
Edouard Samarut
No Relationships to Disclose
 
Maud Aumont
No Relationships to Disclose
 
Morgan Zenatri
No Relationships to Disclose
 
Delphine Loussouarn
No Relationships to Disclose
 
Veronique Quillien
No Relationships to Disclose
 
Francois Bocquet
No Relationships to Disclose
 
Lea Payen-Gay
No Relationships to Disclose
 
Younes Mahi
Employment - Eurobiodev
Stock and Other Ownership Interests - Exact Sciences
 
Alexandre Prieur
Leadership - ECS Progastrin
Stock and Other Ownership Interests - ECS Progastrin
Patents, Royalties, Other Intellectual Property - ECS Progastrin
 
Marie Robert
Consulting or Advisory Role - Eisai
 
Jean-Sebastien Frenel
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Daiichi Sankyo Europe GmbH; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Novocure; Pfizer; Pierre Fabre; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Lilly; Novartis; Pfizer; Roche; Seagen